813 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target? http://www.zacks.com/stock/news/188645/biotech-stock-roundup-amgen-in-the-news-ariad-a-takeover-target?cid=CS-ZC-FT-188645 Sep 02, 2015 - ARIAD's (ARIA) shares shot up on acquisition rumors; Amgen (AMGN) gained FDA approval for its potential blockbuster treatment, Repatha.
Regeneron and Sanofi Present Encouraging Praluent Data http://www.zacks.com/stock/news/188756/regeneron-and-sanofi-present-encouraging-praluent-data?cid=CS-ZC-FT-188756 Sep 02, 2015 - Regeneron Pharmaceuticals, Inc. (REGN) and its partner Sanofi (SNY) presented encouraging data from a phase III study on their Praluent, at the ESC Congress 2015.
Stock Market News for September 11, 2015 http://www.zacks.com/stock/news/189724/stock-market-news-for-september-11-2015?cid=CS-ZC-FT-189724 Sep 11, 2015 - Benchmarks ended modestly higher on Thursday amid rise in oil prices and uncertainty about the timing of a rate hike
Amgen Seeks FDA Approval for Repatha's New Dosing Option http://www.zacks.com/stock/news/189982/amgen-seeks-fda-approval-for-repathas-new-dosing-option?cid=CS-ZC-FT-189982 Sep 14, 2015 - Amgen (AMGN) is looking to gain FDA approval for a 420 mg monthly dose of Repatha to be given as a single injection.
The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA http://www.zacks.com/stock/news/189574/the-zacks-analyst-blog-highlights-amgen-tetraphase-geron-alexion-and-acadia?cid=CS-ZC-FT-189574 Sep 10, 2015 - The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA
Stock Market News for September 22, 2015 http://www.zacks.com/stock/news/190892/stock-market-news-for-september-22-2015?cid=CS-ZC-FT-190892 Sep 22, 2015 - Dennis Lockhart’s willingness to raise rates this year along with gains in financial and technology shares helped benchmarks end in the green on Monday
5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet http://www.zacks.com/stock/news/190981/5-biotech-stocks-hit-hard-by-hillary-clintons-tweet?cid=CS-ZC-FT-190981 Sep 22, 2015 - The biotech sector was hit hard by Hillary Clinton's tweet about skyrocketing drug prices and her intention to come up with a plan.
Stock Market News for September 23, 2015 http://www.zacks.com/stock/news/191065/stock-market-news-for-september-23-2015?cid=CS-ZC-FT-191065 Sep 23, 2015 - Selloff in commodity, auto and biotech stocks dragged benchmarks lower on Tuesday
Amgen (AMGN) Q1 2016 Results - Earnings Call Webcast http://seekingalpha.com/article/3969182-amgen-amgn-q1-2016-results-earnings-call-webcast?source=feed_all_articles Apr 28, 2016 - Earnings Conference Call Start time: April 28, 2016 at 17:30 PM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug http://www.zacks.com/stock/news/224241/biotech-stock-roundup-celgene-in-immuno-oncology-deal-zafgen-drops-lead-drug?cid=CS-ZC-FT-224241 Jul 20, 2016 - While pipeline & regulatory updates will remain in focus, quite a few major biotech companies will be reporting second quarter results over the next few days including Biogen (BIIB).

Pages: 12345678910...82

<<<Page 5>